β-amyloid and the pathomechanisms of Alzheimer’s disease: A comprehensive view

B. Penke, F. Bogár, Lívia F l

Research output: Review article

21 Citations (Scopus)

Abstract

Protein dyshomeostasis is the common mechanism of neurodegenerative diseases such as Alzheimer’s disease (AD). Aging is the key risk factor, as the capacity of the proteostasis network declines during aging. Different cellular stress conditions result in the up-regulation of the neurotrophic, neuroprotective amyloid precursor protein (APP). Enzymatic processing of APP may result in formation of toxic Aβ aggregates (β-amyloids). Protein folding is the basis of life and death. Intracellular Aβ affects the function of subcellular organelles by disturbing the endoplasmic reticulum-mitochondria cross-talk and causing severe Ca2+-dysregulation and lipid dyshomeostasis. The extensive and complex network of proteostasis declines during aging and is not able to maintain the balance between production and disposal of proteins. The effectivity of cellular pathways that safeguard cells against proteotoxic stress (molecular chaperones, aggresomes, the ubiquitin-proteasome system, autophagy) declines with age. Chronic cerebral hypoperfusion causes dysfunction of the blood-brain barrier (BBB), and thus the Aβ-clearance from brain-to-blood decreases. Microglia-mediated clearance of Aβ also declines, Aβ accumulates in the brain and causes neuroinflammation. Recognition of the above mentioned complex pathogenesis pathway resulted in novel drug targets in AD research.

Original languageEnglish
Article number1692
JournalMolecules
Volume22
Issue number10
DOIs
Publication statusPublished - okt. 1 2017

Fingerprint

Amyloid beta-Protein Precursor
Amyloid
Alzheimer Disease
Aging of materials
proteins
Molecular Chaperones
Poisons
Brain
Protein Folding
Autophagy
Microglia
Proteasome Endopeptidase Complex
Ubiquitin
Blood-Brain Barrier
Endoplasmic Reticulum
Neurodegenerative Diseases
Organelles
Neurodegenerative diseases
Protein folding
clearances

ASJC Scopus subject areas

  • Organic Chemistry

Cite this

β-amyloid and the pathomechanisms of Alzheimer’s disease : A comprehensive view. / Penke, B.; Bogár, F.; F l, Lívia.

In: Molecules, Vol. 22, No. 10, 1692, 01.10.2017.

Research output: Review article

@article{232e8b7f8a2b4aa1a60de2b37293a6df,
title = "β-amyloid and the pathomechanisms of Alzheimer’s disease: A comprehensive view",
abstract = "Protein dyshomeostasis is the common mechanism of neurodegenerative diseases such as Alzheimer’s disease (AD). Aging is the key risk factor, as the capacity of the proteostasis network declines during aging. Different cellular stress conditions result in the up-regulation of the neurotrophic, neuroprotective amyloid precursor protein (APP). Enzymatic processing of APP may result in formation of toxic Aβ aggregates (β-amyloids). Protein folding is the basis of life and death. Intracellular Aβ affects the function of subcellular organelles by disturbing the endoplasmic reticulum-mitochondria cross-talk and causing severe Ca2+-dysregulation and lipid dyshomeostasis. The extensive and complex network of proteostasis declines during aging and is not able to maintain the balance between production and disposal of proteins. The effectivity of cellular pathways that safeguard cells against proteotoxic stress (molecular chaperones, aggresomes, the ubiquitin-proteasome system, autophagy) declines with age. Chronic cerebral hypoperfusion causes dysfunction of the blood-brain barrier (BBB), and thus the Aβ-clearance from brain-to-blood decreases. Microglia-mediated clearance of Aβ also declines, Aβ accumulates in the brain and causes neuroinflammation. Recognition of the above mentioned complex pathogenesis pathway resulted in novel drug targets in AD research.",
keywords = "Alzheimer’s disease, APP, Autophagy, Aβ-clearance, Ca2+ dysregulation, ER-mitochondrial axis, Intracellular Aβ, Lipid dyshomeostasis, Molecular chaperones, Neuroinflammation, Protein",
author = "B. Penke and F. Bog{\'a}r and {F l}, L{\'i}via",
year = "2017",
month = "10",
day = "1",
doi = "10.3390/molecules22101692",
language = "English",
volume = "22",
journal = "Molecules",
issn = "1420-3049",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "10",

}

TY - JOUR

T1 - β-amyloid and the pathomechanisms of Alzheimer’s disease

T2 - A comprehensive view

AU - Penke, B.

AU - Bogár, F.

AU - F l, Lívia

PY - 2017/10/1

Y1 - 2017/10/1

N2 - Protein dyshomeostasis is the common mechanism of neurodegenerative diseases such as Alzheimer’s disease (AD). Aging is the key risk factor, as the capacity of the proteostasis network declines during aging. Different cellular stress conditions result in the up-regulation of the neurotrophic, neuroprotective amyloid precursor protein (APP). Enzymatic processing of APP may result in formation of toxic Aβ aggregates (β-amyloids). Protein folding is the basis of life and death. Intracellular Aβ affects the function of subcellular organelles by disturbing the endoplasmic reticulum-mitochondria cross-talk and causing severe Ca2+-dysregulation and lipid dyshomeostasis. The extensive and complex network of proteostasis declines during aging and is not able to maintain the balance between production and disposal of proteins. The effectivity of cellular pathways that safeguard cells against proteotoxic stress (molecular chaperones, aggresomes, the ubiquitin-proteasome system, autophagy) declines with age. Chronic cerebral hypoperfusion causes dysfunction of the blood-brain barrier (BBB), and thus the Aβ-clearance from brain-to-blood decreases. Microglia-mediated clearance of Aβ also declines, Aβ accumulates in the brain and causes neuroinflammation. Recognition of the above mentioned complex pathogenesis pathway resulted in novel drug targets in AD research.

AB - Protein dyshomeostasis is the common mechanism of neurodegenerative diseases such as Alzheimer’s disease (AD). Aging is the key risk factor, as the capacity of the proteostasis network declines during aging. Different cellular stress conditions result in the up-regulation of the neurotrophic, neuroprotective amyloid precursor protein (APP). Enzymatic processing of APP may result in formation of toxic Aβ aggregates (β-amyloids). Protein folding is the basis of life and death. Intracellular Aβ affects the function of subcellular organelles by disturbing the endoplasmic reticulum-mitochondria cross-talk and causing severe Ca2+-dysregulation and lipid dyshomeostasis. The extensive and complex network of proteostasis declines during aging and is not able to maintain the balance between production and disposal of proteins. The effectivity of cellular pathways that safeguard cells against proteotoxic stress (molecular chaperones, aggresomes, the ubiquitin-proteasome system, autophagy) declines with age. Chronic cerebral hypoperfusion causes dysfunction of the blood-brain barrier (BBB), and thus the Aβ-clearance from brain-to-blood decreases. Microglia-mediated clearance of Aβ also declines, Aβ accumulates in the brain and causes neuroinflammation. Recognition of the above mentioned complex pathogenesis pathway resulted in novel drug targets in AD research.

KW - Alzheimer’s disease

KW - APP

KW - Autophagy

KW - Aβ-clearance

KW - Ca2+ dysregulation

KW - ER-mitochondrial axis

KW - Intracellular Aβ

KW - Lipid dyshomeostasis

KW - Molecular chaperones

KW - Neuroinflammation

KW - Protein

UR - http://www.scopus.com/inward/record.url?scp=85032886167&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032886167&partnerID=8YFLogxK

U2 - 10.3390/molecules22101692

DO - 10.3390/molecules22101692

M3 - Review article

C2 - 28994715

AN - SCOPUS:85032886167

VL - 22

JO - Molecules

JF - Molecules

SN - 1420-3049

IS - 10

M1 - 1692

ER -